![The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment | Oncogene The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment | Oncogene](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fonc.2016.129/MediaObjects/41388_2016_Article_BFonc2016129_Fig1_HTML.jpg)
The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment | Oncogene
![STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis | Cancer Research STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis | Cancer Research](https://cancerres.aacrjournals.org/content/canres/76/6/1416/F1.medium.gif)
STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis | Cancer Research
![PDF) The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment PDF) The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment](https://i1.rgstatic.net/publication/302591757_The_ErbB2DEx16_splice_variant_is_a_major_oncogenic_driver_in_breast_cancer_that_promotes_a_pro-metastatic_tumor_microenvironment/links/5dcac90592851c818049a9df/largepreview.png)